
 
													
 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

Lead Product(s) : Flunisolide
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Sponsor : Viatris
Deal Size : Inapplicable
Deal Type : Inapplicable
Flunisolide HFA in Children With Small Airway Disease
Details : Flunisolide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Asthma.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 31, 2015
Lead Product(s) : Flunisolide
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Sponsor : Viatris
Deal Size : Inapplicable
Deal Type : Inapplicable

 Reset All
Reset All